Cargando…

The use of viral vectors in vaccine development

Vaccines represent the single most cost-efficient and equitable way to combat and eradicate infectious diseases. While traditional licensed vaccines consist of either inactivated/attenuated versions of the entire pathogen or subunits of it, most novel experimental vaccines against emerging infectiou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Travieso, Tatianna, Li, Jenny, Mahesh, Sneha, Mello, Juliana Da Fonzeca Redenze E., Blasi, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253346/ https://www.ncbi.nlm.nih.gov/pubmed/35787629 http://dx.doi.org/10.1038/s41541-022-00503-y

Ejemplares similares

Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses
por: Mahesh, Sneha, et al.
Publicado: (2023)

1480. Detection of Multiple HIV Strains in an HIV-positive Transplant Recipient from an Acutely HIV Infected Donor.
por: Alavian, Naseem, et al.
Publicado: (2023)

Developments in Viral Vector-Based Vaccines
por: Ura, Takehiro, et al.
Publicado: (2014)

Viral Vectors for COVID-19 Vaccine Development
por: Lundstrom, Kenneth
Publicado: (2021)

Viral vector vaccines
por: McCann, Naina, et al.
Publicado: (2022)

Viral vectors for malaria vaccine development
por: Li, Shengqiang, et al.
Publicado: (2007)

SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes
por: Kalejaiye, Titilola D., et al.
Publicado: (2022)

Viral Vector Vaccine Development and Application during the COVID-19 Pandemic
por: Deng, Shaofeng, et al.
Publicado: (2022)

Viral vectors for vaccine applications
por: Choi, Youngjoo, et al.
Publicado: (2013)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
por: Mata-Espinosa, Dulce, et al.
Publicado: (2023)

Replicon RNA Viral Vectors as Vaccines
por: Lundstrom, Kenneth
Publicado: (2016)

Viral vector-based influenza vaccines
por: de Vries, Rory D., et al.
Publicado: (2016)

Development of Viral Vectors for Use in Cardiovascular Gene Therapy
por: Williams, Paul D., et al.
Publicado: (2010)

Clinical Advances in Viral-Vectored Influenza Vaccines
por: Sebastian, Sarah, et al.
Publicado: (2018)

Viral Vector Vaccines against Bluetongue Virus
por: Jiménez-Cabello, Luis, et al.
Publicado: (2020)

Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats
por: Vrba, Sophia M., et al.
Publicado: (2020)

Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19
por: Lundstrom, Kenneth
Publicado: (2020)

Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
por: Wang, Shen, et al.
Publicado: (2023)

Vero cell upstream bioprocess development for the production of viral vectors and vaccines
por: Kiesslich, Sascha, et al.
Publicado: (2020)

Replicating and non-replicating viral vectors for vaccine development
por: Robert-Guroff, Marjorie
Publicado: (2007)

Antigen delivery systems for veterinary vaccine development: Viral-vector based delivery systems
por: Brun, Alejandro, et al.
Publicado: (2008)

Utilization of Viral Vector Vaccines in Preparing for Future Pandemics
por: Hofmeyer, Kimberly A., et al.
Publicado: (2022)

Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
por: Elkashif, Ahmed, et al.
Publicado: (2021)

Engineering influenza viral vectors
por: Li, Junwei, et al.
Publicado: (2013)

Viral Vectors for Veterinary Vaccines
por: Sheppard, Michael
Publicado: (1999)

The Development of Functional Non-Viral Vectors for Gene Delivery
por: Patil, Suryaji, et al.
Publicado: (2019)

Development of Streptococcus pneumoniae Vaccines Using Live Vectors
por: Wang, Shifeng, et al.
Publicado: (2014)

Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design
por: Kaynarcalidan, Onur, et al.
Publicado: (2021)

Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena
por: Chavda, Vivek P., et al.
Publicado: (2022)

Development of Viral Vectors for Gene Therapy for Chronic Pain
por: Huang, Yu, et al.
Publicado: (2011)

Foamy Virus Integrase in Development of Viral Vector for Gene Therapy
por: Kim, Jinsun, et al.
Publicado: (2020)

E-cigarette and food flavoring diacetyl alters airway cell morphology, inflammatory and antiviral response, and susceptibility to SARS-CoV-2
por: Langel, Stephanie N., et al.
Publicado: (2022)

Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
por: Chang, Aiquan, et al.
Publicado: (2022)

COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity
por: Lee, Mi-Hyun, et al.
Publicado: (2022)

Novel Viral Vectored Vaccines for the Prevention of Influenza
por: Lambe, Teresa
Publicado: (2012)

Viral Vectors in Gene Therapy
por: Lundstrom, Kenneth
Publicado: (2018)

Viral Vector-Based Gene Therapy
por: Li, Xuedan, et al.
Publicado: (2023)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
por: Isakova-Sivak, Irina, et al.
Publicado: (2022)

Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development
por: Halstead, Scott B.
Publicado: (2021)

Retinal Vein Occlusion Amongst People Vaccinated by mRNA- and Viral Vector- COVID-19 Vaccines: A Systematic Review
por: Rachman, Maria Jessica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fk5aba13p199095dk4mm4i7bvv